GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (FRA:ACT) » Definitions » 3-Year EPS without NRI Growth Rate

AlzChem Group AG (FRA:ACT) 3-Year EPS without NRI Growth Rate : 20.70% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is AlzChem Group AG 3-Year EPS without NRI Growth Rate?

AlzChem Group AG's EPS without NRI for the three months ended in Dec. 2023 was €1.09.

During the past 12 months, AlzChem Group AG's average EPS without NRI Growth Rate was 31.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 20.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of AlzChem Group AG was 20.70% per year. The lowest was -70.60% per year. And the median was -0.30% per year.


Competitive Comparison of AlzChem Group AG's 3-Year EPS without NRI Growth Rate

For the Specialty Chemicals subindustry, AlzChem Group AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AlzChem Group AG's 3-Year EPS without NRI Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, AlzChem Group AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where AlzChem Group AG's 3-Year EPS without NRI Growth Rate falls into.



AlzChem Group AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


AlzChem Group AG  (FRA:ACT) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


AlzChem Group AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (FRA:ACT) Business Description

Industry
Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (FRA:ACT) Headlines